Trimethadione 300 mg Oral Capsule
RxNorm 204511
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 204511 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: trimethadione 300 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Trimethadione 300 mg Oral Capsule
(Atom ID: 12325281)
FN
Full form of descriptor (FN):
Product containing precisely trimethadione 300 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10318095)
PSN
Prescribable Name (PSN):
Trimethadione 300 mg Oral Capsule
(Atom ID: 6361120)
PT
Designated preferred name (PT):
Trimethadione 300 mg oral capsule
(Atom ID: 10322047)
Patient Education
Trimethadione
Trimethadione is used to control absence seizures (petit mal; a type of seizure in which there is a very short loss of awareness during which the person may stare straight ahead or blink his eyes and does not respond to others) when other medications will not work. Trimethadione is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.